7.43 USD
-0.07 (-0.93%)
7.43 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to VMD. VMD was compared to 101 industry peers in the Health Care Providers & Services industry. VMD has an excellent profitability rating, but there are some minor concerns on its financial health. VMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make VMD suitable for growth investing!
1. Profitability
1.1 Basic Checks
VMD had positive earnings in the past year.
In the past year VMD had a positive cash flow from operations.
In the past 5 years VMD has always been profitable.
In the past 5 years VMD always reported a positive cash flow from operatings.
1.2 Ratios
VMD has a better Return On Assets (6.73%) than 87.13% of its industry peers.
With a decent Return On Equity value of 10.19%, VMD is doing good in the industry, outperforming 72.28% of the companies in the same industry.
VMD has a better Return On Invested Capital (7.79%) than 73.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VMD is in line with the industry average of 9.58%.
The 3 year average ROIC (7.66%) for VMD is below the current ROIC(7.79%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| ROIC | 7.8% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
VMD has a better Profit Margin (5.34%) than 79.21% of its industry peers.
In the last couple of years the Profit Margin of VMD has declined.
VMD's Operating Margin of 6.83% is fine compared to the rest of the industry. VMD outperforms 70.30% of its industry peers.
In the last couple of years the Operating Margin of VMD has declined.
VMD's Gross Margin of 57.89% is amongst the best of the industry. VMD outperforms 80.20% of its industry peers.
VMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.83% | ||
| PM (TTM) | 5.34% | ||
| GM | 57.89% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
VMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
VMD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VMD has more shares outstanding
VMD has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.72 indicates that VMD is not in any danger for bankruptcy at the moment.
VMD's Altman-Z score of 4.72 is amongst the best of the industry. VMD outperforms 82.18% of its industry peers.
The Debt to FCF ratio of VMD is 3.93, which is a good value as it means it would take VMD, 3.93 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.93, VMD is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that VMD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, VMD is in the better half of the industry, outperforming 73.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.93 | ||
| Altman-Z | 4.72 |
ROIC/WACC0.86
WACC9.07%
2.3 Liquidity
A Current Ratio of 1.13 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a worse Current ratio (1.13) than 62.38% of its industry peers.
VMD has a Quick Ratio of 1.01. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of VMD (1.01) is worse than 64.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
VMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.22%, which is quite impressive.
Measured over the past 5 years, VMD shows a small growth in Earnings Per Share. The EPS has been growing by 4.01% on average per year.
VMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.90%.
Measured over the past years, VMD shows a very strong growth in Revenue. The Revenue has been growing by 22.80% on average per year.
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
Revenue 1Y (TTM)18.9%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
3.2 Future
The Earnings Per Share is expected to grow by 30.77% on average over the next years. This is a very strong growth
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.73% yearly.
EPS Next Y31.66%
EPS Next 2Y35.63%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue Next Year19.16%
Revenue Next 2Y18.3%
Revenue Next 3Y19.73%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 22.52 indicates a rather expensive valuation of VMD.
Compared to the rest of the industry, the Price/Earnings ratio of VMD indicates a somewhat cheap valuation: VMD is cheaper than 65.35% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. VMD is around the same levels.
VMD is valuated correctly with a Price/Forward Earnings ratio of 14.42.
VMD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. VMD is cheaper than 77.23% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (23.13), we can say VMD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.52 | ||
| Fwd PE | 14.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VMD is valued cheaply inside the industry as 88.12% of the companies are valued more expensively.
VMD's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 52.46 | ||
| EV/EBITDA | 6.53 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VMD may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 30.77% in the coming years.
PEG (NY)0.71
PEG (5Y)5.61
EPS Next 2Y35.63%
EPS Next 3Y30.77%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
7.43
-0.07 (-0.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners66.48%
Inst Owner ChangeN/A
Ins Owners13.52%
Ins Owner Change1%
Market Cap282.49M
Revenue(TTM)254.79M
Net Income(TTM)13.61M
Analysts80
Price Target13.26 (78.47%)
Short Float %1.18%
Short Ratio2.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)0
Avg EPS beat(4)-2.17%
Min EPS beat(4)-5.7%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-9.3%
EPS beat(12)3
Avg EPS beat(12)-5.6%
EPS beat(16)4
Avg EPS beat(16)-8.04%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-1.06%
Revenue beat(4)1
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.24%
Revenue beat(8)5
Avg Revenue beat(8)-0.38%
Revenue beat(12)7
Avg Revenue beat(12)-0.14%
Revenue beat(16)11
Avg Revenue beat(16)0.8%
PT rev (1m)0%
PT rev (3m)-4.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.33%
EPS NY rev (1m)0.46%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.12%
Revenue NY rev (1m)0.7%
Revenue NY rev (3m)0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.52 | ||
| Fwd PE | 14.42 | ||
| P/S | 1.11 | ||
| P/FCF | 52.46 | ||
| P/OCF | 5.83 | ||
| P/B | 2.11 | ||
| P/tB | 3.83 | ||
| EV/EBITDA | 6.53 |
EPS(TTM)0.33
EY4.44%
EPS(NY)0.52
Fwd EY6.93%
FCF(TTM)0.14
FCFY1.91%
OCF(TTM)1.27
OCFY17.16%
SpS6.7
BVpS3.51
TBVpS1.94
PEG (NY)0.71
PEG (5Y)5.61
Graham Number5.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| ROCE | 11% | ||
| ROIC | 7.8% | ||
| ROICexc | 8.38% | ||
| ROICexgc | 14.13% | ||
| OM | 6.83% | ||
| PM (TTM) | 5.34% | ||
| GM | 57.89% | ||
| FCFM | 2.11% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexgc growth 3Y2.65%
ROICexgc growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score5
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.93 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 157.16% | ||
| Cap/Sales | 16.91% | ||
| Interest Coverage | 21.97 | ||
| Cash Conversion | 108.16% | ||
| Profit Quality | 39.56% | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 4.72 |
F-Score5
WACC9.07%
ROIC/WACC0.86
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
EPS Next Y31.66%
EPS Next 2Y35.63%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue 1Y (TTM)18.9%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
Revenue Next Year19.16%
Revenue Next 2Y18.3%
Revenue Next 3Y19.73%
Revenue Next 5YN/A
EBIT growth 1Y7.34%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year245.03%
EBIT Next 3Y64.45%
EBIT Next 5YN/A
FCF growth 1Y-66.11%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y22.32%
OCF growth 3Y20.23%
OCF growth 5Y15.41%
VIEMED HEALTHCARE INC / VMD FAQ
What is the ChartMill fundamental rating of VIEMED HEALTHCARE INC (VMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to VMD.
Can you provide the valuation status for VIEMED HEALTHCARE INC?
ChartMill assigns a valuation rating of 6 / 10 to VIEMED HEALTHCARE INC (VMD). This can be considered as Fairly Valued.
Can you provide the profitability details for VIEMED HEALTHCARE INC?
VIEMED HEALTHCARE INC (VMD) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VIEMED HEALTHCARE INC (VMD) stock?
The Price/Earnings (PE) ratio for VIEMED HEALTHCARE INC (VMD) is 22.52 and the Price/Book (PB) ratio is 2.11.
What is the earnings growth outlook for VIEMED HEALTHCARE INC?
The Earnings per Share (EPS) of VIEMED HEALTHCARE INC (VMD) is expected to grow by 31.66% in the next year.